4.8 Article

Induction of Hepatitis by JNK-Mediated Expression of TNF-α

Journal

CELL
Volume 136, Issue 2, Pages 249-260

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2008.11.017

Keywords

-

Funding

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. NCI NIH HHS [R01 CA065861, R01 CA065861-14] Funding Source: Medline
  3. NIAID NIH HHS [R01 AI051454] Funding Source: Medline
  4. NIDDK NIH HHS [P30 DK032520-26, P30 DK 32520, P30 DK032520] Funding Source: Medline

Ask authors/readers for more resources

The c-Jun NH2-terminal kinase (JNK) signaling pathway has been implicated in the development of tumor necrosis factor (TNF)-dependent hepatitis. JNK may play a critical role in hepatocytes during TNF-stimulated cell death in vivo. To test this hypothesis, we examined the phenotype of mice with compound disruption of the Jnk1 and Jnk2 genes. Mice with loss of JNK1/2 expression in hepatocytes exhibited no defects in the development of hepatitis compared with control mice, whereas mice with loss of JNK1/2 in the hematopoietic compartment exhibited a profound defect in hepatitis that was associated with markedly reduced expression of TNF-alpha. These data indicate that JNK is required for TNF-alpha expression but not for TNF-alpha-stimulated death of hepatocytes. Indeed, TNF-alpha induced similar hepatic damage in both mice with hepatocyte-specific JNK1/2 deficiency and control mice. These observations confirm a role for JNK in the development of hepatitis but identify hematopoietic cells as the site of the essential function of JNK.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available